Hemab Therapeutics Holdings, Inc. Common Stock (COAG) vs ORIC Pharmaceuticals, Inc. (ORIC)
A side-by-side comparison of Hemab Therapeutics Holdings, Inc. Common Stock and ORIC Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COAG
Hemab Therapeutics Holdings, Inc. Common Stock
$28.82HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
ORIC
ORIC Pharmaceuticals, Inc.
$11.93HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
Total return — COAG vs ORIC
growth of $100 · dividends reinvested · last 1yCOAG -10.0% (-10.0%/yr)ORIC +27.8% (+27.8%/yr)ORIC compounded faster over this window
COAG ORIC
COAG vs ORIC: by the numbers
- •COAG is the larger company ($1.35B vs $1.23B market cap).
Metrics side by side
Valuation
| Metric | COAG | ORIC |
|---|---|---|
| P/B ratio | 2.96 | 3.24 |
Profitability
| Metric | COAG | ORIC |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -36.81% |
| ROIC | -38.09% | -40.32% |
Growth (annualized)
| Metric | COAG | ORIC |
|---|---|---|
| Total return CAGR (5Y) | N/A | -8.73% |
Go deeper
Dig into the metrics
Hemab Therapeutics Holdings, Inc. Common Stock ROEORIC Pharmaceuticals ROEHemab Therapeutics Holdings, Inc. Common Stock operating marginORIC Pharmaceuticals operating marginHemab Therapeutics Holdings, Inc. Common Stock revenue growthORIC Pharmaceuticals revenue growthHemab Therapeutics Holdings, Inc. Common Stock free cash flowORIC Pharmaceuticals free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.